Authors: Hamill, TG Duggan, ME Perkins, JJ

Citation: Tg. Hamill et al., The synthesis of the alpha(v)beta(3) integrin receptor ligand [I-125]L-775,219., J LABEL C R, 44(1), 2001, pp. 55-59

Authors: Duggan, ME Duong, LT Fisher, JE Hamill, TG Hoffman, WF Huff, JR Ihle, NC Leu, CT Nagy, RM Perkins, JJ Rodan, SB Wesolowski, G Whitman, DB Zartman, AE Rodan, GA Hartman, GD

Citation: Me. Duggan et al., Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist, J MED CHEM, 43(20), 2000, pp. 3736-3745

Authors: Perkins, JJ Sanson-Fisher, RW Byles, JE Tiller, K

Citation: Jj. Perkins et al., Factors relating to cervical screening in New South Wales, Australia, HEALTH PLAC, 5(3), 1999, pp. 223-233

Authors: Hartman, GD Duggan, ME Hoffman, WF Meissner, RJ Perkins, JJ Zartman, AE Naylor-Olsen, AM Cook, JJ Glass, JD Lynch, RJ Zhang, GX Gould, RJ

Citation: Gd. Hartman et al., Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors., BIOORG MED, 9(6), 1999, pp. 863-868

Authors: Perkins, JJ Zartman, AE Meissner, RS

Citation: Jj. Perkins et al., Synthesis of 2-(alkylamino)benzimidazoles, TETRAHEDR L, 40(6), 1999, pp. 1103-1106